RALYH:BISTRal Yatirim Holding A.S. Analysis
Data as of 2026-07-22 - not real-time
TRY 264.25
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Ral Yatirim Holding is trading well above its short‑ and long‑term moving averages (264.25 vs SMA20 208, SMA50 226.8, SMA200 213.4) and the MACD indicator is firmly bullish, suggesting short‑term momentum. However, the RSI sits at 68, edging toward overbought territory, and the stock is priced far above its DCF fair value (223.5) and a PE of 90.5 versus an industry average of 30.7, indicating significant overvaluation. Fundamentally, the company shows modest revenue growth (2.9%), thin operating margins (2.9%), a high debt‑to‑equity ratio (38.5), and negative free cash flow (-1.8 B TRY), which raise concerns about financial resilience.
Volatility is extremely high (≈97% 30‑day), beta is near zero (low market correlation), and there is no dividend payout, further limiting downside protection. The combination of bullish technicals with weak fundamentals, high leverage, and macro‑economic exposure to Turkey suggests caution for investors.
Volatility is extremely high (≈97% 30‑day), beta is near zero (low market correlation), and there is no dividend payout, further limiting downside protection. The combination of bullish technicals with weak fundamentals, high leverage, and macro‑economic exposure to Turkey suggests caution for investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD and price above key moving averages
- RSI approaching overbought levels
- High valuation relative to earnings and DCF
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Persistently high PE and price above fair value
- Negative free cash flow and elevated debt load
- Elevated volatility and lack of dividend income
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential upside from operational cash flow improvements
- Low beta indicating limited market correlation risk
- Structural risks from Turkish macro‑environment and leverage
Key Metrics & Analysis
Financial Health
Revenue Growth286.00%
Profit Margin33.72%
P/E Ratio90.5
ROE58.19%
ROA6.71%
Debt/Equity38.50
P/B Ratio12.4
Op. Cash FlowTRY3.1B
Free Cash FlowTRY-1800081920
Industry P/E30.7
Technical Analysis
TrendNeutral
RSI68.1
SupportTRY 137.60
ResistanceTRY 273.25
MA 20TRY 208.02
MA 50TRY 226.83
MA 200TRY 213.40
MACDBullish
VolumeDecreasing
Fear & Greed Index91.71
Valuation
Fair ValueTRY 223.51
GradeOvervalued
TypeValue
Risk Assessment
Beta-0.10
Volatility96.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.